Recon: FDA schedules June adcomm to review Lilly Alzheimer’s drug; Medtronic cleared to sell renal denervation device in China

• UnitedHealth CEO downplays his company’s control over physicians (STAT)
• The world is relying on the United States to get value-based drug pricing right (STAT)
• Lilly gets June adcomm for Alzheimer's drug donanemab, following earlier delay (Endpoints)
• Vertex starts gene therapy Casgevy in five patients (STAT)
• ‘Remarkable interest’: Madrigal touts early launch progress for first MASH drug Rezdiffra despite VA hurdle (Fierce Pharma)
• Sharp looks to cut into sterile injectable market growth with expansion of Pennsylvania packaging plant (Fierce Pharma)
• US FDA panel to discuss first psychedelic-assisted PTSD treatment next month (Reuters)

• WHO’s top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology (STAT)
• Exclusive: Feng Zhang CRISPR startup gathers patents, locking up rights to family of editing tech (Endpoints)
• Medtronic wins approval to sell renal denervation device in China (MedTech Dive)
• KKR to buy India's Healthium Medtech at $839 mln valuation, sources say (Reuters)
• Pandemic Treaty Talks Go Up To The Wire (Pink Sheet)

• LabCentral helped create 6,300 jobs and 19 IPOs. Amid a slump, demand for lab space has slowed (Endpoints)
• Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates (Reuters)
• Lykos’ MDMA therapy to go before FDA committee; GSK expands work with BioVersys (Endpoints)
• Lonnie Moulder's Zenas closes a $200M Series C to broaden lead drug's autoimmune potential (Endpoints)
• Flagship commits $50M to new startup that scours viral proteins for new drugs (Endpoints)
• Memo Therapeutics refuels with $22M to expand trial for infection-fighting antibody in kidney transplant recipients (Endpoints)
• Kenvue maps out hundreds of layoffs as service pact with J&J winds down (Fierce Pharma)
• Shah Capital urges Novavax shareholders to vote against three directors (Reuters)

• Virtual first is flaming out. A virtual-second model can refresh telehealth (STAT)
• As digital health unicorns are pressured to do more with less, Transcarent gets a fresh $126M (Endpoints)
• Fresenius Medical beats earnings expectations, keeps outlook; shares sink (Reuters)
• CMR Surgical names new CFO (MedTech Dive)
• Masimo’s at-home baby monitor cleared for use without prescription (MedTech Dive)
• Robotic-Assisted Treatment For Enlarged Prostate Shows Promising Results (MedTech Insight)
• GE HealthCare’s New Investigational MRI Promises Advancements On Neurological Disease Research (MedTech Insight)
• Can a Device Be Found Not Substantially Equivalent Because of Cybersecurity Risks? A Review of FDA’s Draft Guidance on Cybersecurity in Medical Devices (FDA Law Blog)

• As livestock move around the country, so does H5N1. The U.S. needs real-time tracking of livestock movements (STAT)
• At Milken Institute conference, CDC director Mandy Cohen talks public health preparedness (STAT)
• ‘Dark Money’ Casts Shadow As Industry, Legislators Push For Litigation-Funding Transparency (MedTech Insight)
• Expert Proposes AI Device Reimbursement Model ‘Like Netflix’ (MedTech Insight)